1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 1:Clinical features and serum levels of T4, free T3, and TSH before and after treatment
Patient Initial Diagnosis* Level Before Treatment Clinical Diagnosis After Treatment Clinical Assessment After Treatment‖ Level After Treatment T4 (nmol/L)† T3 (pmol/L)‡ TSH (mU/L)§ T4 (nmol/L)† T3 (pmol/L)‡ TSH (mU/L)§ 1 Hyperthyroidism 284 32.2 <0.1 Euthyroidism Symptoms remitted 116 7.8 <0.1 2 Hyperthyroidism 267 23+ <0.1 Euthyroidism Symptoms remitted 61 2.2+ <0.1 3 Hyperthyroidism 263 13.2+ <0.1 Euthyroidism Symptoms remitted 112 4.6+ <0.1 4 Hyperthyroidism 196 28.2 <0.1 Euthyroidism Symptoms remitted 73 7.2 <0.1 5 Hyperthyroidism 142 11.1 <0.1 Euthyroidism Symptoms remitted 53 2.8+ <0.1 6 Hyperthyroidism 287 39.7+ <0.1 Euthyroidism Symptoms remitted 121 6.1+ 1.4 7 Hyperthyroidism >300 55.9 <0.1 Euthyroidism Symptoms remitted 66 6.2 <0.1 8 Hyperthyroidism 307 >45 <0.1 Toxicity Symptoms remitted 229 20.4 <0.1 9 Hypothyroidism 2 2.9 43.3 Euthyroidism Symptoms remitted 81 6.9 2.5 10 Hypothyroidism <15 NA 76.5 Euthyroidism Symptoms remitted 94 NA 3.4 11 Hypothyroidism <15 NA >100 Euthyroidism Symptoms remitted 113 NA 25.9
* All patients with hyperthyroidism had neuropsychological symptoms of anxiety, agitation, restlessness, and hyperactivity. All patients with hypothyroidism had neuropsychological symptoms of tiredness, lethargy, mental slowing, and depression.
† Normal range, 60–160 nmol/L.
‡ Normal ranges, 5.4–9.3 pmol/L (assay 1) and 2.5–5.3 pmol/L (assay 2) (denoted with +).
§ Normal range, 0.4–4.0 mU/L.
‖ In all patients, symptoms remitted at clinical assessment after treatment.